Stock listing
NASDAQ:RADX Radiopharm Theranostics Limited Stock
US listing (NASDAQ) of Radiopharm Theranostics Limited · home listing ASX:RAD
Follow Radiopharm Theranostics Limited into a list and get an email when it puts out news.
Share price · NASDAQ:RADX
$0.90 USD -0.11 (-10.9%)
Close on Oct 27, 2026
- Day range
- $0.90 – $0.951 USDOct 27, 2026
- Volume
- 25,072 sharesOct 27, 2026
- Market cap
- $13.13M USDAt the close on Oct 27, 2026 · price × 14.59M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:RAD · Home | $0.0040 AUD | -0.0010 (-20.0%) | 8,923,721 | $0.0050 | $0.0050 | $0.0040 | $0.0050 | Delayed 15+ min · 10:57 AM GMT+11, Nov 2, 2026 |
| NASDAQ:RADX | $0.90 USD | -0.11 (-10.9%) | 25,072 | $0.95 | $0.951 | $0.90 | $1.01 | Close on Oct 27, 2026 |
- Ticker
- NASDAQ:RADX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 38 slides
Latest news
Financings
Registered direct offering of american Depositary Shares with unregistered warrants
Jul 27, 2026
Announced: about US$4.1M · US$3.16 a share · Warrants at US$3.79 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: RAD101 registrational study, advancing therapeutic programs, strategic partnering, working capital and general corporate purposes
Private placement of ordinary shares with attaching options
Jul 27, 2026 · US$4.68M
Announced: about A$6.7M · Warrants at A$0.018
Use of proceeds: RAD101 registrational study, advancing therapeutic programs, strategic partnering, working capital and general corporate purposes
Share purchase plan of ordinary shares with attaching options
Jul 27, 2026 · US$4.2M
Announced: up to A$6M · Warrants at A$0.018
Use of proceeds: RAD101 registrational study, advancing therapeutic programs, strategic partnering, working capital and general corporate purposes
Decks
Investor Presentation (October 2026)
Investor deck · 38 slides · October 2026
Investor Presentation (July 2026)
Investor deck · 31 slides · Jul 24, 2026
Investor Presentation (June 2026)
Investor deck · 41 slides · June 2026
Investor Presentation (December 2025)
Investor deck · 60 slides · December 2025
Radiopharm Theranostics Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 48 in the last 12 months · 132 in all · newest Oct 30, 2026 · oldest 2021
- Decks
- 28 decks · latest October 2026
Where Radiopharm Theranostics Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:RAD · Home listing | ASX | Australia | AUD |
| NASDAQ:RADX · This page | NASDAQ | United States | USD |
| OTC:RDPTF | OTC | United States | USD |
| BOATS:RADX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Radiopharm Theranostics Limited.